Implementation of an Efferent Loop Stimulation Protocol Prior to Ileostomy Closure at La Paz University Hospital
Launched by HOSPITAL UNIVERSITARIO LA PAZ · May 7, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is examining a new approach to help patients who need to have their ileostomy closed after surgery. An ileostomy is when part of the intestine is brought to the surface of the abdomen, allowing waste to exit the body through a stoma (an opening). While this procedure can be necessary and life-saving, it can also affect patients' lives in various ways. The trial is testing whether a simple technique called efferent loop stimulation, done before closing the ileostomy, can improve recovery outcomes for patients. The goal is to see if this method can help reduce complications, shorten hospital stays, and enhance overall quality of life for patients undergoing this procedure.
To participate in the trial, individuals must be over 18 years old and have an ileostomy that their doctor believes should be closed. They should be willing to understand the study's purpose and risks, give consent, and commit to follow-up visits. However, those who do not wish to have their ileostomy closed or cannot complete the required stimulation before surgery will not be eligible. Participants can expect a supportive environment as they take part in this important research, which could lead to better care for future patients facing similar surgeries.
Gender
ALL
Eligibility criteria
- IInclusion Criteria:
- • 1. Subjects must be able to understand the purpose and risks of the study, provide informed consent, and authorise the use of confidential health information.
- • 2. Patients over 18 years of age who, regardless of the underlying cause, have an ileostomy and a medical indication for intestinal transit reconstruction by a general surgeon.
- • 3. Subjects who are able and willing to participate and to comply with follow-up for the duration of the study.
- Exclusion Criteria:
- • 1. Subjects with an ileostomy who do not wish to undergo intestinal reconstruction.
- • 2. Subjects who are unable to complete at least two weeks of efferent loop stimulation prior to reconstruction surgery.
- • 3. Subjects who do not provide consent to participate in the study.
About Hospital Universitario La Paz
Hospital Universitario La Paz, a leading academic medical center in Spain, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient safety and ethical standards, the hospital collaborates with multidisciplinary teams of healthcare professionals and researchers to conduct cutting-edge studies across various medical fields. Its commitment to excellence in clinical practice, education, and research positions Hospital Universitario La Paz at the forefront of medical advancements, aiming to improve patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Luis Asensio, Consultant
Principal Investigator
Hospital Universitario La Paz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported